Login
|
Register
News
Media
Insights
Peer Exchange
OncNurse TV
Webinars
Podcasts
Resources
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Gynecologic Cancers
Supportive Care
Blood Cancers
Prevention
Genetics
Nurse Navigation
Immuno-Oncology
Drug Safety
Skin Cancer/Melanoma
Brain Cancer
Childhood/AYA Cancer
Head and Neck Cancers
Adverse Event Management
Contributors
Conferences
Partners
Advocacy
Associations
Schools of Nursing
Publications
CE
Register now to learn about a new option for relapsed or refractory follicular lymphoma
Web Exclusives
Ilixadencel Gets Orphan Drug Designation for Soft Tissue Sarcoma
BY KRISTI ROSA
FDA Grants Toripalimab Fast Track Status for Mucosal Melanoma
BY KRISTI ROSA
1 in 5 Patients Engage in Nonmedical Opioid Use
BY BRIELLE BENYON
Lung-Sparing Nodule Resection Needs Multidisciplinary Approach in Lung Cancer
BY JESSICA HERGERT
Immunotherapy May Highlight Neoadjuvant Treatment's Use in Lung Cancer
BY CAROLINE SEYMOUR
Retifanlimab Granted Priority Review for Squamous Cell Carcinoma of the Anal Canal
BY KRISTI ROSA
FDA Approves Cabozantinib Plus Nivolumab for Frontline Advanced RCC
BY BRIELLE BENYON
COVID-19 Vaccine for Patients With Cancer: NCCN Guidance
BY BRIELLE BENYON
Aspirin May Offer Survival Advantage in Breast, Bladder Cancer
BY BRIELLE BENYON
Maintain COVID-19 Precautions After Vaccine Distribution
BY BRIELLE BENYON
Next Page >>
External Resources
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
OncNurse Resources
Newsroom
Continuing Education
Discussions
Web Exclusives
About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.